Literature DB >> 19495971

Rotenone induces cell death of cholinergic neurons in an organotypic co-culture brain slice model.

Celine Ullrich1, Christian Humpel.   

Abstract

In Alzheimer and Parkinson's disease cell death of cholinergic and dopaminergic neurons are characteristic hallmarks, respectively. It is well established that rotenone, an inhibitor of complex I of the electron transport chain, induces cell death of dopaminergic neurons, however, not much is known on the effects of rotenone on cholinergic neurons. The aim of the present study was to evaluate the effects of rotenone on cholinergic neurons in an organotypic in vitro brain co-slice model. When co-cultures were treated with 10 μM rotenone for 24 h a significantly decreased number of cholinergic neurons was found in the basal nucleus of Meynert but not in the dorsal striatum. This cell death exhibited apoptotic DAPI-positive malformed nuclei and enhanced TUNEL-positive cells. In summary, inhibition of complex I of the electron transport chain may play a role in neurodegeneration of cholinergic neurons.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19495971      PMCID: PMC4311144          DOI: 10.1007/s11064-009-0014-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  44 in total

1.  Identification of necrotic cell death by the TUNEL assay in the hypoxic-ischemic neonatal rat brain.

Authors:  C de Torres; F Munell; I Ferrer; J Reventós; A Macaya
Journal:  Neurosci Lett       Date:  1997-07-11       Impact factor: 3.046

2.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease.

Authors:  R Betarbet; T B Sherer; G MacKenzie; M Garcia-Osuna; A V Panov; J T Greenamyre
Journal:  Nat Neurosci       Date:  2000-12       Impact factor: 24.884

3.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

Review 4.  Oxidative stress and genetics in the pathogenesis of Parkinson's disease.

Authors:  Y Zhang; V L Dawson; T M Dawson
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

Review 5.  Apoptosis and neurologic disease.

Authors:  L S Honig; R N Rosenberg
Journal:  Am J Med       Date:  2000-03       Impact factor: 4.965

6.  Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease.

Authors:  E Masliah; M Alford; R DeTeresa; M Mallory; L Hansen
Journal:  Ann Neurol       Date:  1996-11       Impact factor: 10.422

Review 7.  Oxidative stress signalling in Alzheimer's disease.

Authors:  Xiongwei Zhu; Arun K Raina; Hyoung-Gon Lee; Gemma Casadesus; Mark A Smith; George Perry
Journal:  Brain Res       Date:  2004-03-12       Impact factor: 3.252

8.  Tumor necrosis factor-alpha triggers cell death of sensitized potassium chloride-stimulated cholinergic neurons.

Authors:  Birgit Zassler; Carla Weis; Christian Humpel
Journal:  Brain Res Mol Brain Res       Date:  2003-05-12

Review 9.  Glial cytokines in Alzheimer's disease: review and pathogenic implications.

Authors:  R E Mrak; J G Sheng; W S Griffin
Journal:  Hum Pathol       Date:  1995-08       Impact factor: 3.466

10.  Mesencephalic grafts increase preprotachykinin-A mRNA expression in striatal grafts in an in oculo co-graft model.

Authors:  C Humpel; M Johansson; J Marksteiner; A Saria; I Strömberg
Journal:  Regul Pept       Date:  1995-03-07
View more
  14 in total

Review 1.  Tracking extranigral degeneration in animal models of Parkinson's disease: quest for effective therapeutic strategies.

Authors:  Varduhi H Knaryan; Supriti Samantaray; Charlene Le Gal; Swapan K Ray; Naren L Banik
Journal:  J Neurochem       Date:  2011-06-17       Impact factor: 5.372

2.  BAG2 prevents Tau hyperphosphorylation and increases p62/SQSTM1 in cell models of neurodegeneration.

Authors:  Raquel S Lima; Daniel C Carrettiero; Merari F R Ferrari
Journal:  Mol Biol Rep       Date:  2022-05-25       Impact factor: 2.742

3.  Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy.

Authors:  Naomi Chadderton; Arpad Palfi; Sophia Millington-Ward; Oliverio Gobbo; Nora Overlack; Matthew Carrigan; Mary O'Reilly; Matthew Campbell; Carsten Ehrhardt; Uwe Wolfrum; Peter Humphries; Paul F Kenna; G Jane Farrar
Journal:  Eur J Hum Genet       Date:  2012-06-06       Impact factor: 4.246

4.  Transcriptome analysis of a rotenone model of parkinsonism reveals complex I-tied and -untied toxicity mechanisms common to neurodegenerative diseases.

Authors:  Yofre Cabeza-Arvelaiz; Robert H Schiestl
Journal:  PLoS One       Date:  2012-09-07       Impact factor: 3.240

5.  Organotypic vibrosections: novel whole sagittal brain cultures.

Authors:  Celine Ullrich; Nina Daschil; Christian Humpel
Journal:  J Neurosci Methods       Date:  2011-07-30       Impact factor: 2.390

6.  Intravenous infusion of monocytes isolated from 2-week-old mice enhances clearance of Beta-amyloid plaques in an Alzheimer mouse model.

Authors:  Lindsay A Hohsfield; Christian Humpel
Journal:  PLoS One       Date:  2015-04-01       Impact factor: 3.240

Review 7.  Role of environmental contaminants in the etiology of Alzheimer's disease: a review.

Authors:  Manivannan Yegambaram; Bhagyashree Manivannan; Thomas G Beach; Rolf U Halden
Journal:  Curr Alzheimer Res       Date:  2015       Impact factor: 3.498

8.  Nifedipine and nimodipine protect dopaminergic substantia nigra neurons against axotomy-induced cell death in rat vibrosections via modulating inflammatory responses.

Authors:  Nina Daschil; Christian Humpel
Journal:  Brain Res       Date:  2014-07-16       Impact factor: 3.252

Review 9.  Organotypic brain slice cultures: A review.

Authors:  C Humpel
Journal:  Neuroscience       Date:  2015-08-05       Impact factor: 3.590

Review 10.  Organotypic Cultures as a Model to Study Adult Neurogenesis in CNS Disorders.

Authors:  Fabio Cavaliere; Monica Benito-Muñoz; Carlos Matute
Journal:  Stem Cells Int       Date:  2016-04-05       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.